The Food and Drug Administration (FDA) approved a new drug to treat a disorder causing the growth of non-cancerous tumors on ...

University of Queensland research using natural killer cells may lead to the first new treatment for a devastating childhood ...

Nathan Congdon, MD, highlights a recent study showing how virtual mentor-mentee relationships through Orbis' free ...

IFB-088 (icerguastat) was safe and significantly slowed disease progression in certain people with ALS in a Phase 2 clinical trial.

Compared with adults aged 65 and older, those aged 18 to 64 are more affected by long COVID neurologic symptoms.

To Know in detail about the Neuroblastoma market outlook, drug uptake, treatment scenario, and epidemiology trends, Click here: Neuroblastoma Market Forecast Some of the key facts of the Neuroblastoma ...

The study used gold-standard autopsy confirmation to show that a blood test for Alzheimer's disease accurately detected ...

In this video, Annick Desjardins, MD, professor of neurosurgery, professor of neurology and member of the Duke Cancer Institute, explains how clinicians may treat patients with gliomas of different ...

Our mission is to support the development of Clinical Psychology, both as a profession and as a body of knowledge and skills. By working collaboratively with a number of organisations including the ...

GD2 CAR-modified T cells have induced complete responses in some children with neuroblastoma. Clinical trials with EGFRvIII CARs and IL-13 zetakine are underway for adults with brain tumors ...

Here's what to know about flu symptoms in 2025, how to tell if it's something else, and how to protect yourself: But there are some differences. COVID-19 can show up later than the cold or flu ...